lacosamide oral solution
Generic: lacosamide oral
Labeler: florida pharmaceutical products, llcDrug Facts
Product Profile
Brand Name
lacosamide oral solution
Generic Name
lacosamide oral
Labeler
florida pharmaceutical products, llc
Dosage Form
SOLUTION
Routes
Active Ingredients
lacosamide 10 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
71921-411
Product ID
71921-411_ceee316d-6ad9-4bca-9416-47ae954d174f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA220386
DEA Schedule
cv
Listing Expiration
2027-12-31
Marketing Start
2026-01-30
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
71921411
Hyphenated Format
71921-411
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lacosamide oral solution (source: ndc)
Generic Name
lacosamide oral (source: ndc)
Application Number
ANDA220386 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/mL
Packaging
- 1 BOTTLE in 1 CARTON (71921-411-71) / 200 mL in 1 BOTTLE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ceee316d-6ad9-4bca-9416-47ae954d174f", "openfda": {"nui": ["N0000008486"], "upc": ["0371921411719"], "unii": ["563KS2PQY5"], "rxcui": ["993856"], "spl_set_id": ["ba4e2e28-7dc3-47b3-9c2c-34e0b1f39fb8"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Florida Pharmaceutical Products, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (71921-411-71) / 200 mL in 1 BOTTLE", "package_ndc": "71921-411-71", "marketing_start_date": "20260130"}], "brand_name": "Lacosamide Oral Solution", "product_id": "71921-411_ceee316d-6ad9-4bca-9416-47ae954d174f", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "71921-411", "dea_schedule": "CV", "generic_name": "Lacosamide Oral", "labeler_name": "Florida Pharmaceutical Products, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide Oral Solution", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "10 mg/mL"}], "application_number": "ANDA220386", "marketing_category": "ANDA", "marketing_start_date": "20260130", "listing_expiration_date": "20271231"}